Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Mar 3, 2025
Dr. Rekha Kumar, Chief Medical Officer at Found, is focused on weight care, not just weight management, to provide personalized medical care. GLP-1 medications have changed the landscape of obesity treatment, providing doctors with more effective tools for patients, but they don't work for everyone. With this telehealth approach, patients engage with the platform to determine a tailored treatment plan based on each patient's unique biology, lifestyle, and history. There is also an increased stigma around obesity due to the availability of GLP-1s, reinforcing the need for new medications and approaches based on real-world outcomes.
Rekha explains, "I would say the way GLP-1s have changed this entire field of medicine is that doctors now feel like they have a tool that works that they can offer their patients. Although GLP-1s don't work perfectly in everybody, and there may be people who don't respond well to them for decades or longer than decades, doctors felt like all they could tell patients was to eat less and exercise more. Even when doctors said that, I think they felt like what they were offering wasn't very useful. Now, an actual tool, or a class of medicine, can be very effective for patients."
"I am looped into the conversation on stigma. In some ways, it’s been helpful to that conversation in the sense that people like Oprah have come out and said that now she realizes biology is involved in body weight control and that thin people are wired differently. They don't have as much of a preoccupation with food or noise."
"In some ways, it's reduced the stigma by bringing attention to the role of biology and hormones that contribute to our body weight that we don't have control of. Unfortunately, now that there is this tool that's so powerful, some would say that it's made weight stigma worse because if somebody chooses not to take this medicine, they're judged for not wanting to be thin."
#JoinFound #WeightCare #WeightManagment #Obesity #GLP1
